Facebook Linkedin Twitter
Inside Precision Medicine Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

Health care economics

Immune checkpoint inhibitors: Interaction between PD-1 (blue) on a T-cell and PD-L1 (red) on a cancer cell blocked by therapeutic antibodies
News & Features

Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing

0
3D image illustrating immune cells attacking cancer cells in immunotherapy such as that used in cancers with mismatch repair deficiency
News & Features

New AI-Based Tool Predicts Patient’s ICI Response Without Genomics

0
Firing Neurons Hologram
News & Features

Potential Action: SiteOne’s $100M Series C to Advance Non-Opioid Pain Drugs

Jonathan D. Grinstein, PhD
0
Sickle Cell disease - 3D Illustration of sickled blood cells on a dark background
News & Features

New CMS Payment Model Launched for Sickle Cell Gene Therapy

0
Finger Prick
News & Features

Global Rate of Diabetes Doubles While Many Patients Go Without Treatment 

0
Antibody drug conjugated with cytotoxic payload. Synthetic Biology
News & Features

Radiopharma Startup Alpha-9 Nets $175M Series C

0
Lungs filled with people
News & Features

International Survey Highlights Suboptimal Uptake of Lung Cancer Biomarker Testing

Laura Cowen
0
Superluminal Medicines
Informatics

Burn Rubber: Superluminal Medicines Gets $120M to Take GPCR Drugs to Clinic

Jonathan D. Grinstein, PhD
0
3D Illustration of human kidneys to illustrate kidney transplants
News & Features

eGenesis Raises $191 Million for Gene Edited Pig Organs

0
mix race scientists team analyzing medical data on virtual board medicine healthcare concept hospital interior
Informatics

Realyze Intelligence’s Human-in-the-Loop AI Widens Clinical Trials as Care

Jonathan D. Grinstein, PhD
0
123...27Page 1 of 27

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine